APA (7th ed.) Citation

Li, J., Pohl, L., Schüler, J., Korzeniewski, N., Reimold, P., Kaczorowski, A., . . . Duensing, S. (2021). Targeting the proteasome in advanced renal cell carcinoma: Complexity and limitations of patient-individualized preclinical drug discovery. Biomedicines, 9(6), . https://doi.org/10.3390/biomedicines9060627

Chicago Style (17th ed.) Citation

Li, Jielin, et al. "Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-individualized Preclinical Drug Discovery." Biomedicines 9, no. 6 (2021). https://doi.org/10.3390/biomedicines9060627.

MLA (9th ed.) Citation

Li, Jielin, et al. "Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-individualized Preclinical Drug Discovery." Biomedicines, vol. 9, no. 6, 2021, https://doi.org/10.3390/biomedicines9060627.